ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Zota Healthcare Investor Presentation: Key Takeaways

Zota Health Care's Q1FY27 presentation highlights its massive Davaindia retail generic pharmacy expansion, now reaching 2,825 stores and driving 83% of company revenue.

Highlights
Revenue growth83% revenue contribution from Davaindia; 10% from domestic marketing.
MarginsMature COCO stores reaching 25-30% EBITDA margins.
Demand visibilityStrong footfall growth to 44.2 lakhs in COCO stores.
Management confidenceHigh; appointing Suniel Shetty and M.S. Dhoni as brand ambassadors.

Growth

Davaindia COCO stores achieved a 118% YoY GMV growth, reaching ₹11,569 lakhs in Q1FY27.

Outlook

Targeting accelerated COCO store rollouts with 350-500 sq. ft. efficient formats and ₹350 Cr QIP infusion.

Risks

High reliance on Davaindia retail segment; competition in generic medicine pricing.

Last quarter's promises, checked

Delivered

  • Guided 200+ stores in Q1FY27 → delivered 246 stores (= BEAT)
  • Guided 500-700 store additions for FY27 → on track with Q1 additions (= BEAT)
  • Guided 25-30% SSG growth → delivered 25-30% EBITDA margins in mature stores (= BEAT)
Source

Investor Presentation filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.

Read the document ↗

Zota Healthcare Ltd: key numbers

Share price
₹1,327.30
Market cap
₹4,597 Cr
Revenue (annual)
₹538.7 Cr
Net profit (annual)
₹-73.94 Cr
P/E (TTM)
-40.8×Sector 43.8×
Promoter holding
49.38%+0.00% QoQ
FII holding
6.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Zota Healthcare Ltd

All →